Non-Invasive Tools for Diagnosing & Staging NAFLD & Liver Fibrosis: Current Status & Perspectives

Time: 10:30 am
day: Post Conference Seminar Day


• Discovering imaging modalities for assessing liver steatosis and fibrosis stage
• Explaining Omics (lipidomics, genomics, epigenomics, transcriptomics, glycomics and proteomics) alone and together with clinical data for developing diagnostic algorithms with the use of machine learning tools
• Understanding challenges related to the development of non-invasive diagnostic tools and ways to overcome them